Congressional Investigation into Alzheimer’s Drug Aduhelm Faults the F.D.A. and Biogen
Posted inAdvertising and Marketing Biogen Inc Drugs (Pharmaceuticals) Elderly Food and Drug Administration House Committee on Energy and Commerce House Committee on Oversight and Government Reform Labeling and Labels (Product) Maloney, Carolyn B Pallone, Frank Jr

Congressional Investigation into Alzheimer’s Drug Aduhelm Faults the F.D.A. and Biogen

The report said the F.D.A.’s approval process for Aduhelm was “rife with irregularities” and criticized Biogen for setting an “unjustifiably high price.”
China’s Abrupt Covid Pivot Leaves Many Without Medicines
Posted inBeijing (China) BioNTech SE China Coronavirus (2019-nCoV) Drugs (Pharmaceuticals) Drugstores East Asia Hong Kong Hospitals Ibuprofen (Drug) Jinan (China) Pain-Relieving Drugs Paxlovid (Drug) Pfizer Inc Shanghai (China) Shortages

China’s Abrupt Covid Pivot Leaves Many Without Medicines

Millions are desperate to get their hands on fever-reducing drugs and antivirals such as Pfizer’s Paxlovid as infections across China outpace supplies.
Can a Federally Funded ‘Netflix Model’ Fix the Broken Market for Antibiotics?
Posted inDrug Resistance (Microbial) Drugs (Pharmaceuticals) Food and Drug Administration Hospitals Infections Law and Legislation Politics and Government Regulation and Deregulation of Industry United States Politics and Government

Can a Federally Funded ‘Netflix Model’ Fix the Broken Market for Antibiotics?

Shortages and drug-resistant germs have renewed attention on a $6 billion proposal in Congress that would reconfigure the way antimicrobial drugs are developed and sold.